MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Relationship between brain bioelectrical activity during REM/NREM sleep, grey matter changes and visual disorders in patients with RBD in Parkinson’s disease

    O. Alenikova, T. Svinkovskaya, N. Alenikov (Minsk, Belarus)

    Objective: To investigate the brain bioelectric activity during REM/NREM sleep and determine the relationship with visual impairment and structural brain alteration in non-demented PD patients…
  • 2022 International Congress

    Eye-of-the-Tiger sign in Progressive Supranuclear Palsy

    R. Machado, I. Carvalho, D. Damas, J. Lemos, A. Morgadinho, F. Moreira (Coimbra, Portugal)

    Objective: To present a rare case of eye-of-the-tiger sign in a patient with progressive supranuclear palsy (PSP). Background: The eye-of-the-tiger is a neuroradiologic sign appearing…
  • 2022 International Congress

    Initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease in Slovenia

    E. Pipan, N. Zupančič Križnar, L. Ocepek, R. Rajnar, M. Kramberger, M. Menih, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To study the initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) in routine clinical practice at two University Medical Centers in Slovenia. Background: The…
  • 2022 International Congress

    COVID-19-associated antecollis: a case report

    S. Kopishinskaia, I. Velichko, O. Ivanovskaia (Kirov, Russian Federation)

    Objective: demonstrate a clinical case of antecollis that occurred in a patient after COVID-19 disease. Background: despite numerous studies in favor of the attack of…
  • 2022 International Congress

    BBP-671, AN INVESTIGATIONAL MODULATOR OF PANTOTHENATE KINASES, DEMONSTRATES PROOF OF CONCEPT IN A PKAN MOUSE MODEL AND TARGET ENGAGEMENT IN HUMANS

    D. Gretler, A. Jurecka, R. Sukhun, C. Henry, A. Wade, M. Harden, C. Subramanian, M. Frank, R. Lee, C. Rock, S. Jackowski, S. Rao, U. Sinha (San Francisco, USA)

    Objective: Efficacy of BBP-671 as a potential therapy for pantothenate kinase-associated neurodegeneration (PKAN) was evaluated in a PKAN mouse model. Safety, PK, and PD of…
  • 2022 International Congress

    Longitudinal brain perfusion changes correlated with UPDRS Total in a Phase I mesenchymal stem cell trial for Parkinson’s disease

    M. Schiess, J. Suescun, C. Adams, E. Tharp, K. Block, M. Doursout, T. Ellmore (Houston, USA)

    Objective: Explore changes in correlations between brain perfusion and UPDRS-Total (UPDRS-T) after a single infusion of allogeneic bone marrow-derived mesenchymal stem cells (MSC). Background: Our…
  • 2022 International Congress

    The functional neuroanatomy of cortical slowing predicts clinical features of Parkinson’s disease

    A. Wiesman, E. Fon, S. Baillet (Montreal, Canada)

    Objective: Investigate the relevance of spatially-resolved estimates of cortical neural slowing for predicting clinical features of patients with Parkinson’s disease (PD). Background: In patients with…
  • 2022 International Congress

    Are Subjective Cognitive Complaints a predictor of future cognitive decline in Parkinson´s Disease? – A longitudinal study

    M. Magriço, B. Meira, M. Fernandes, M. Saraiva, M. Salavisa, C. Borbinha, J. Maro, F. Ladeira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

    Objective: We aim to determine whether subjective cognitive complaints (SCC) may predict the development of cognitive impairment in Parkinson´s Disease (PD) Background: Subjective cognitive complaints…
  • 2022 International Congress

    Deep Brain Stimulation for Rare Neurodegenerative Diseases: Three-Center Experience

    N. Durmaz çelik, B. Samanci, G. Yalçın çakmaklı, A. Aksoy Gündoğdu, E. Erzurumluoğlu, Y. Samanci, M. Vural, B. Bilgiç, H. Hanağası, B. Elibol, S. özkan (Eskişehir, Turkey)

    Objective: To report deep brain stimulation (DBS) outcomes of rare neurodegenerative movement disorders from three tertiary movement disorders centers in Turkey. Background: Deep brain stimulation…
  • 2022 International Congress

    Compound heterozygous mutation of the Beta galactosidase 1 gene presenting with familial dystonia and spondylo-epiphyseal dysplasia

    A. Elavarasi, A. Anand, A. Garg, K. Garg, M. Singh, M. Tripathi, D. Vibha, R. Singh (New Delhi, India)

    Objective: To describe a family with dystonia and spondylo-epiphyseal dysplasia Background: Childhood onset Generalized dystonia is usually associated with genetic causes. Method: We present a…
  • « Previous Page
  • 1
  • …
  • 803
  • 804
  • 805
  • 806
  • 807
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley